GAM
GILD icon

Groupama Asset Management’s Gilead Sciences GILD Stock Holding History

Groupama Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.89M Buy
70,390
+32,400
+85% +$4.27M 0.11% 88
2026
Q1 		$5.29M Sell
37,990
-13,240
-26% -$1.85M 0.08% 101
2025
Q4 		$6.29M Sell
51,230
-1,051
-2% -$128K 0.09% 99
2025
Q3 		$5.8M Buy
52,281
+16,848
+48% +$1.92M 0.09% 100
2025
Q2 		$3.92M Sell
35,433
-12,492
-26% -$1.33M 0.06% 128
2025
Q1 		$5.36M Sell
47,925
-6,247
-12% -$645K 0.11% 99
2024
Q4 		$4.98M Sell
54,172
-5,871
-10% -$529K 0.1% 114
2024
Q3 		$4.04M Buy
60,043
+24,956
+71% +$1.9M 0.11% 118
2024
Q2 		$2.41M Sell
35,087
-4,788
-12% -$320K 0.03% 189
2024
Q1 		$4.48M Sell
39,875
-22,381
-36% -$1.72M 0.08% 145
2023
Q4 		$5.04M Buy
+62,256
New +$4.84M 0.13% 113

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Groupama Asset Management's GILD Position: Q2 2026 in Review

Groupama Asset Management increased its Gilead Sciences (GILD) stake by 85% in Q2 2026, buying an estimated $4.27M and bringing the position to 70,390 shares worth $8.89M. The position accounts for 0.11% of the portfolio, ranked #88.

Groupama Asset Management first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Groupama Asset Management held 70,390 shares of Gilead Sciences worth $8.89M as of Q2 2026.
  • Groupama Asset Management bought 32,400 Gilead Sciences shares in Q2 2026, an estimated $4.27M.
  • Gilead Sciences made up 0.11% of Groupama Asset Management's portfolio in Q2 2026, its #88 holding.
  • Groupama Asset Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.